A tesamorelin clinic can prescribe this FDA-approved GHRH peptide for visceral fat. Learn who qualifies, typical costs, and what monitoring is required.
Tesamorelin is a prescription-only peptide that a licensed clinic can prescribe to reduce visceral abdominal fat, but the FDA has approved it only for adults with HIV-associated lipodystrophy. A tesamorelin clinic is the medical practice — often a telehealth or hormone-optimization office — that screens patients, orders labs, and manages the prescription. Clinics may legally prescribe tesamorelin off-label, so the quality of the medical oversight matters far more than the marketing.
What a Tesamorelin Clinic Actually Does
A real clinic is a medical practice, not a storefront. Before writing a tesamorelin rx, a provider should confirm the drug is appropriate for you and that nothing in your history makes it unsafe.
Expect the intake process to include:
- Medical history and medication review, including any prior cancer diagnosis or pituitary condition.
- Baseline labs, typically IGF-1, fasting glucose or A1c, and liver and kidney panels.
- A written protocol showing dose, injection timing, and the date of your first follow-up.
- Injection technique training, since tesamorelin is injected subcutaneously into the abdomen.
- Scheduled re-testing, because tesamorelin raises IGF-1 and that level needs watching.
A clinic that skips baseline labs and follow-up visits is selling product, not care. Tesamorelin requires ongoing monitoring, and any practice that ignores that is not practicing medicine responsibly.
Who Qualifies for Tesamorelin — and Who Should Not Use It
Tesamorelin is FDA-approved for reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It is not approved for general weight loss, cosmetic fat reduction, anti-aging, or athletic performance.
Many clinics prescribe it off-label to patients who do not have HIV, and off-label prescribing is legal in the United States. The evidence base outside HIV lipodystrophy is much thinner, though, and insurers almost never cover it in those cases.
Patients who should avoid tesamorelin
- Anyone with active cancer, or a recent malignancy not cleared by an oncologist.
- People who are pregnant, planning pregnancy, or breastfeeding.
- Patients with pituitary gland disease, prior pituitary surgery, or hypothalamic disorders.
- Anyone with a known allergy to tesamorelin or its inactive ingredients.
Diabetes, thyroid disease, and already-elevated IGF-1 levels also deserve a conversation with a physician, because tesamorelin can shift glucose metabolism and push IGF-1 higher.
Typical Tesamorelin Protocol and Monitoring Schedule
The labeled approach is a once-daily subcutaneous injection, usually given in the evening. The table below reflects standard prescribing rather than what any single clinic advertises.
| Protocol element | Standard approach | Why it matters |
|---|---|---|
| Dose | 1.4 mg to 2 mg daily | Formulations differ in injection volume |
| Route | Subcutaneous, abdomen | Rotate sites to limit irritation |
| Baseline labs | IGF-1, glucose/A1c, lipids, liver and kidney panels | Establishes a safe starting point |
| Follow-up | IGF-1 and metabolic labs every 3 to 6 months | Detects IGF-1 drift and glucose changes |
| Studied duration | 26 to 52 weeks in clinical trials | Long-term data beyond that are limited |
Visceral fat changes in trials were measured over months, not weeks. Anyone promising visible results in a few days is overselling the drug.
Cost: Brand-Name vs. Compounded Tesamorelin
Price is the biggest divide between clinics. Brand-name tesamorelin (sold as Egrifta) carries a list price in the thousands of dollars per month, while some clinics charge a few hundred dollars monthly for compounded vials. Those two products are not equivalent.
| Factor | FDA-approved tesamorelin | Compounded tesamorelin |
|---|---|---|
| FDA status | Approved for HIV-associated lipodystrophy | Not FDA-approved |
| Purity and dosing | Standardized by the manufacturer | Varies by pharmacy and batch |
| Typical monthly cost | Often $3,000+ before insurance | Commonly $300 to $1,000 |
| Insurance | Sometimes covered with prior authorization | Not covered |
Insurance coverage for tesamorelin generally requires a documented HIV diagnosis and lipodystrophy, which means most off-label patients pay cash. Some TRT-focused telehealth brands, including TRT Nation, list tesamorelin as an add-on to their hormone programs. Verify who is actually prescribing, which pharmacy fills the order, and what monitoring is included before you compare prices.
Tesamorelin vs. Other Fat-Loss Peptides
The peptide market is crowded, and most competitors have far less human data than tesamorelin. The comparison below covers the names patients ask about most.
| Peptide | Primary mechanism | FDA status | Typical role in a clinic |
|---|---|---|---|
| Tesamorelin | GHRH analog; raises natural growth hormone and IGF-1 | Approved for HIV lipodystrophy | Prescribed for visceral fat reduction |
| AOD-9604 | Growth hormone fragment studied for fat metabolism | Not approved | Marketed for fat loss, often "research only" |
| MOTS-c | Mitochondrial-derived peptide studied in metabolic regulation | Not approved | Marketed for metabolic support |
| Ipamorelin | Ghrelin-receptor agonist that stimulates GH release | Not approved | Stacked with other secretagogues |
Patients frequently search aod 9604 vs tesamorelin, and the honest answer is that the two are not close in evidence quality: tesamorelin has large randomized human trials, while AOD-9604's human data are sparse.
Discussions about aod 9604 mots c tesamorelin ipamorelin usually combine a fat-targeting fragment with growth-hormone secretagogues, a mix with almost no controlled human research behind it. If a clinic offers aod 9604 with tesamorelin as a package, ask for the published studies it is based on. Marketing for a tesamorelin aod-9604 stack typically claims additive fat loss, and that claim has not been tested in a controlled trial.
Side Effects, Risks, and Realistic Expectations
Side effects in trials were common but usually manageable: injection site reactions, joint pain, muscle aches, swelling in the hands and feet, and carpal tunnel symptoms. Some patients also see blood sugar increases.
Tesamorelin raises IGF-1, and chronically elevated IGF-1 is a theoretical concern in some cancers. That is why monitoring matters and why patients with active or recent malignancy are excluded from treatment.
What to expect realistically:
- Visceral fat reductions in trials were modest and measured over six months or more.
- Scale weight may barely move, because tesamorelin targets visceral fat rather than total body weight.
- Effects generally reverse after the drug is stopped.
Tesamorelin is not a cure for obesity and is not a substitute for diet, exercise, or treatment of underlying conditions.
How to Spot a Tesamorelin Clinic Worth Paying For
Red flags show up early, usually in the sales pitch.
- No baseline labs and no IGF-1 monitoring.
- Vials labeled "for research use only" sold directly to patients.
- Guaranteed weight-loss numbers or before-and-after photos presented as clinical evidence.
- No named physician or nurse practitioner responsible for your care.
- Pressure to prepay six months before any lab work.
A good clinic will tell you what tesamorelin cannot do, put the monitoring plan in writing, and be clear about the total cost of the drug plus labs plus visits. Ask directly whether a physician reviews your labs and what happens if your IGF-1 climbs above the reference range.
If you have HIV-associated lipodystrophy, ask whether the clinic will pursue insurance coverage, because the drug is expensive enough to make the paperwork worthwhile. This article is informational only and is not medical advice; talk with a licensed clinician about whether tesamorelin is appropriate for you.
Frequently Asked Questions
Is it legal to get tesamorelin from a clinic in the US?
Yes. Tesamorelin is an FDA-approved prescription drug, and licensed US clinicians can prescribe it, including off-label for patients who do not have HIV. What you cannot legally buy is tesamorelin sold as a supplement or a "research chemical" marketed for human use. A clinic offering it without a prescription, labs, and follow-up is operating outside normal medical practice.
How much does tesamorelin cost through a clinic?
Brand-name tesamorelin often lists above $3,000 per month before insurance, and coverage usually requires an HIV-associated lipodystrophy diagnosis. Compounded versions sold through clinics commonly run $300 to $1,000 per month, plus consultation fees and lab costs. Ask for the all-in monthly price rather than just the drug price.
How long does tesamorelin take to work, and what testing is needed?
Clinical trials measured visceral fat reductions over 26 to 52 weeks, so noticeable changes generally take months rather than weeks. A clinic should order baseline IGF-1, glucose or A1c, and liver and kidney labs before you start, then repeat IGF-1 monitoring every three to six months. Tesamorelin raises IGF-1, so skipping that follow-up is a safety problem.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.